OPKO Health SG&A Expenses 2010-2025 | OPK
OPKO Health sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| OPKO Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $304 |
| 2023 | $301 |
| 2022 | $373 |
| 2021 | $469 |
| 2020 | $356 |
| 2019 | $343 |
| 2018 | $358 |
| 2017 | $415 |
| 2016 | $407 |
| 2015 | $197 |
| 2014 | $58 |
| 2013 | $55 |
| 2012 | $28 |
| 2011 | $19 |
| 2010 | $18 |
| 2009 | $10 |
| OPKO Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $59 |
| 2024-12-31 | $67 |
| 2024-09-30 | $98 |
| 2024-06-30 | $69 |
| 2024-03-31 | $70 |
| 2023-12-31 | $73 |
| 2023-09-30 | $72 |
| 2023-06-30 | $80 |
| 2023-03-31 | $76 |
| 2022-12-31 | $74 |
| 2022-09-30 | $80 |
| 2022-06-30 | $101 |
| 2022-03-31 | $118 |
| 2021-12-31 | $138 |
| 2021-09-30 | $105 |
| 2021-06-30 | $113 |
| 2021-03-31 | $112 |
| 2020-12-31 | $102 |
| 2020-09-30 | $100 |
| 2020-06-30 | $78 |
| 2020-03-31 | $76 |
| 2019-12-31 | $79 |
| 2019-09-30 | $81 |
| 2019-06-30 | $88 |
| 2019-03-31 | $95 |
| 2018-12-31 | $95 |
| 2018-09-30 | $84 |
| 2018-06-30 | $88 |
| 2018-03-31 | $92 |
| 2017-12-31 | $96 |
| 2017-09-30 | $103 |
| 2017-06-30 | $106 |
| 2017-03-31 | $110 |
| 2016-12-31 | $165 |
| 2016-09-30 | $125 |
| 2016-06-30 | $118 |
| 2016-03-31 | |
| 2015-12-31 | $103 |
| 2015-09-30 | $55 |
| 2015-06-30 | $21 |
| 2015-03-31 | $17 |
| 2014-12-31 | $15 |
| 2014-09-30 | $14 |
| 2014-06-30 | $15 |
| 2014-03-31 | $14 |
| 2013-12-31 | $15 |
| 2013-09-30 | $14 |
| 2013-06-30 | $14 |
| 2013-03-31 | $12 |
| 2012-12-31 | $10 |
| 2012-09-30 | $7 |
| 2012-06-30 | $5 |
| 2012-03-31 | $5 |
| 2011-12-31 | $5 |
| 2011-09-30 | $4 |
| 2011-06-30 | $5 |
| 2011-03-31 | $5 |
| 2010-12-31 | $4 |
| 2010-09-30 | $4 |
| 2010-06-30 | $6 |
| 2010-03-31 | $4 |
| 2009-12-31 | $1 |
| 2009-09-30 | $3 |
| 2009-06-30 | $3 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.047B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.463B | 83.86 |
| Thermo Fisher Scientific (TMO) | United States | $155.573B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.256B | 29.67 |
| Alcon (ALC) | Switzerland | $42.967B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $42.445B | 48.78 |
| DexCom (DXCM) | United States | $33.345B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.362B | 15.33 |
| Mettler-Toledo (MTD) | United States | $24.800B | 29.49 |
| STERIS (STE) | Ireland | $23.464B | 25.84 |
| Waters (WAT) | United States | $21.120B | 29.80 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.882B | 0.00 |
| Hologic (HOLX) | United States | $14.509B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Penumbra (PEN) | United States | $9.820B | 77.08 |
| Masimo (MASI) | United States | $9.039B | 33.34 |
| Globus Medical (GMED) | United States | $7.963B | 18.97 |
| Glaukos (GKOS) | United States | $5.775B | 0.00 |
| Teleflex (TFX) | United States | $5.284B | 8.72 |
| TransMedics (TMDX) | United States | $4.399B | 95.63 |
| Integer Holdings (ITGR) | United States | $4.252B | 22.28 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.497B | 14.87 |
| Veracyte (VCYT) | United States | $2.100B | 29.46 |
| Nihon Kohden (NHNKY) | Japan | $2.016B | 23.12 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.593B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.48 |
| Tandem Diabetes Care (TNDM) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.002B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.772B | 39.17 |
| SiBone (SIBN) | United States | $0.771B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.650B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.563B | 8.76 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.529B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.526B | 12.32 |
| Delcath Systems (DCTH) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.477B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.433B | 11.51 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.401B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.359B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.336B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.42 |
| Biosig Technologies (BSGM) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |